TFF Pharmaceuticals, Inc.
NASDAQ:TFFP
1.63 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q3 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 0.65 | 0.203 | 0.734 | 0 | 0.333 | 0.051 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of Revenue
| 0.141 | 0.14 | 0.131 | 0.125 | 0.124 | 0.123 | 0.121 | 0.101 | 0.089 | 0.077 | 0.077 | 0.028 | 0.004 | 0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross Profit
| 0.51 | 0.063 | 0.603 | -0.125 | 0.21 | -0.072 | -0.121 | -0.101 | -0.089 | -0.077 | -0.077 | -0.028 | -0.004 | -0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross Profit Ratio
| 0.784 | 0.31 | 0.822 | 0 | 0.629 | -1.395 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Reseach & Development Expenses
| 2.588 | 3.556 | 2.974 | 2.387 | 2.682 | 4.019 | 4.136 | 4.026 | 5.111 | 5.262 | 6.92 | 6.34 | 2.762 | 5.278 | 3.055 | 2.824 | 2.568 | 2.236 | 3.268 | 2.564 | 1.32 | 1.671 | 0.14 |
General & Administrative Expenses
| 2.024 | 2.32 | 2.509 | 2.269 | 2.67 | 3.119 | 3.558 | 3.342 | 3.69 | 3.246 | 3.188 | 2.388 | 2.351 | 2.647 | 2.864 | 2.255 | 1.275 | 1.618 | 1.444 | 0.301 | 0.889 | 0.532 | 0.466 |
Selling & Marketing Expenses
| -0.141 | -0.14 | -0.131 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 1.884 | 2.298 | 2.378 | 2.269 | 2.67 | 3.119 | 3.558 | 3.342 | 3.69 | 3.246 | 3.188 | 2.388 | 2.351 | 2.647 | 2.864 | 2.255 | 1.275 | 1.618 | 1.444 | 0.301 | 0.889 | 0.532 | 0.466 |
Other Expenses
| 0 | 0 | 0.166 | -0.077 | -0.037 | -0.051 | -0.313 | -0.088 | 0.021 | 0.057 | 0.037 | -0.013 | 0.442 | 0.231 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Expenses
| 4.472 | 5.854 | 5.352 | 4.421 | 5.019 | 7.086 | 7.381 | 7.281 | 8.773 | 8.44 | 10.096 | 8.678 | 5.111 | 7.901 | 5.919 | 5.079 | 3.843 | 3.853 | 4.712 | 2.864 | 2.209 | 2.202 | 0.606 |
Operating Income
| -4.613 | -5.994 | -5.483 | -4.421 | -5.019 | -7.086 | -7.381 | -7.281 | -8.773 | -8.44 | -10.096 | -8.678 | -5.111 | -7.901 | -5.919 | -5.079 | -3.843 | -3.853 | -4.712 | -2.864 | -2.209 | -2.202 | -0.606 |
Operating Income Ratio
| -7.094 | -29.488 | -7.471 | 0 | -15.056 | -137.791 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Other Income Expenses Net
| 0.134 | 0.259 | 0.721 | -0.077 | -0.037 | 0.035 | 0.008 | 0.006 | 0.021 | 0.057 | 0.037 | -0.013 | 0.442 | 0.231 | 0.024 | 0.021 | 0.026 | 0.056 | 0.05 | 0.026 | 0.022 | 0.02 | 0.021 |
Income Before Tax
| -4.479 | -5.735 | -4.762 | -4.409 | -5.02 | -7.051 | -7.373 | -7.275 | -8.746 | -8.376 | -10.05 | -8.679 | -4.656 | -7.655 | -5.895 | -5.058 | -3.817 | -3.797 | -4.662 | -2.838 | -2.187 | -2.183 | -0.585 |
Income Before Tax Ratio
| -6.889 | -28.214 | -6.489 | 0 | -15.06 | -137.109 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Income Tax Expense
| -0 | -0 | 0 | -0.089 | -0.036 | -0.158 | 0.006 | -0.006 | -0.006 | -0.007 | -0.01 | -0.012 | -0.014 | -0.017 | -0.055 | -0.053 | -0.051 | -0.047 | -0.046 | -0.045 | -0.041 | -0.04 | 0 |
Net Income
| -4.479 | -5.735 | -4.762 | -4.409 | -5.02 | -6.893 | -7.379 | -7.268 | -8.746 | -8.376 | -10.05 | -8.679 | -4.656 | -7.655 | -5.895 | -5.058 | -3.817 | -3.797 | -4.662 | -2.838 | -2.187 | -2.183 | -0.585 |
Net Income Ratio
| -6.889 | -28.214 | -6.489 | 0 | -15.06 | -134.032 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS
| -1.22 | -2.4 | -2.01 | -2.32 | -3.47 | -4.76 | -5.1 | -0.29 | -0.34 | -0.33 | -0.4 | -0.34 | -0.18 | -0.33 | -0.26 | -0.24 | -0.2 | -0.2 | -0.33 | -0.16 | -0.12 | -0.12 | -0.033 |
EPS Diluted
| -1.22 | -2.4 | -2.01 | -2.32 | -3.47 | -4.76 | -5.1 | -0.29 | -0.34 | -0.33 | -0.4 | -0.34 | -0.18 | -0.33 | -0.26 | -0.24 | -0.2 | -0.2 | -0.33 | -0.16 | -0.12 | -0.12 | -0.033 |
EBITDA
| -4.472 | -5.854 | -5.352 | -4.295 | -4.895 | -7.086 | -7.26 | -7.179 | -8.684 | -8.363 | -10.019 | -8.649 | -5.107 | -7.901 | -5.919 | -5.079 | -3.843 | -3.853 | -4.712 | -2.864 | -2.209 | -2.202 | -0.606 |
EBITDA Ratio
| -6.878 | -28.799 | -7.293 | 0 | -14.685 | -137.791 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |